Clinton Group’s AbbVie ABBV Stock Holding History

Clinton Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-82,667	Closed	-$7.66M	–	184
2018 Q2	$7.66M	Sell	82,667 -103,862	-56%	-$10.1M	1.2%	4
2018 Q1	$17.7M	Buy	186,529 +141,663	+316%	+$15.6M	1.89%	2
2017 Q4	$4.34M	Buy	+44,866	New	+$4.23M	0.38%	86
2017 Q3	–	Sell	-55,912	Closed	-$4.05M	–	372
2017 Q2	$4.05M	Buy	55,912 +46,949	+524%	+$3.16M	0.41%	75
2017 Q1	$584K	Buy	+8,963	New	+$564K	0.03%	589
2016 Q4	–	Sell	-27,444	Closed	-$1.73M	–	793
2016 Q3	$1.73M	Buy	27,444 +17,146	+166%	+$1.11M	0.08%	318
2016 Q2	$638K	Sell	10,298 -83,648	-89%	-$5.1M	0.03%	595
2016 Q1	$5.37M	Buy	+93,946	New	+$5.24M	0.32%	72
2015 Q4	–	Sell	-6,293	Closed	-$342K	–	734
2015 Q3	$342K	Buy	6,293 +2,855	+83%	+$186K	0.03%	524
2015 Q2	$231K	Sell	3,438 -3,868	-53%	-$253K	0.03%	518
2015 Q1	$428K	Sell	7,306 -27,990	-79%	-$1.69M	0.11%	274
2014 Q4	$2.31M	Buy	+35,296	New	+$2.23M	0.72%	12
2014 Q2	–	Sell	-8,810	Closed	-$453K	–	306
2014 Q1	$453K	Buy	+8,810	New	+$445K	0.17%	195

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clinton Group's ABBV Position: Q3 2018 in Review

Clinton Group sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 82,667 shares — an estimated $7.66M sold.

Clinton Group first reported a position in ABBV in Q1 2014 and held it in 13 quarters. The position peaked at $17.7M in Q1 2018. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Clinton Group reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
Clinton Group sold 82,667 AbbVie shares in Q3 2018, an estimated $7.66M.
Clinton Group first reported a position in AbbVie in Q1 2014 and held it in 13 quarters.
Clinton Group's AbbVie position peaked at $17.7M in Q1 2018.
1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.